Metropolis Healthcare Limited announced the approval of its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. The Board of Directors noted the limited review report from the statutory auditors. Additionally, the completion timeline for the sale and transfer of the External Quality Assessment Services Business has been extended by two months.
Metropolis Healthcare Announces Q1 FY27 Financial Results
Metropolis Healthcare Limited has announced the outcome of its Board Meeting held on August 4, 2026. The Board of Directors has approved the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. The limited review report from the Company’s statutory auditors has also been noted and is enclosed with the results. The financial results are now available on the company’s website, www.metropolisindia.com.
Business Transfer Agreement Update
Further to the financial results, the Board of Directors also addressed the ongoing business transfer agreement. The sale and transfer of the External Quality Assessment Services Business to its wholly owned subsidiary, Metropolis Quality Solutions Private Limited, which was originally scheduled for completion within six months of the Business Transfer Agreement dated February 4, 2026, is now expected to take an additional two months to finalize.
Meeting Details
The Board Meeting commenced at 02:00 p.m. IST and concluded at 05:20 p.m. IST on August 4, 2026.
Source: BSE
